SCHEMBL5447451

SCHEMBL5447451

CCCCN1C(=O)CC(=O)N(CC)C1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2 P00734 1/20 0.46
ELANE P08246 1/20 0.46
CTSG P08311 1/20 0.46
CTRC Q99895 1/20 0.46
KDM4E B2RXH2 3/20 0.45
MAPT P10636 4/20 0.45
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
USP2 O75604 2/20 0.45
POLB P06746 1/20 0.45
RECQL P46063 1/20 0.45
BLM P54132 1/20 0.45
GAA P10253 3/20 0.42
HTT P42858 2/20 0.42
HSD17B10 Q99714 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
PTGS1 P23219 3/20 0.38
PTGS2 P35354 3/20 0.38
MGLL Q99685 3/20 0.38
FAAH O00519 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3420629 0.94 MAPT (0.49) F2ELANECTSGCTRCKDM4E
SCHEMBL10972869 0.92 MAPT (0.50) F2ELANECTSGCTRCKDM4E
SCHEMBL10702779 0.92 MAPT (0.50) F2ELANECTSGCTRCKDM4E
SCHEMBL14582192 0.92 F2 (0.50) F2ELANECTSGCTRCKDM4E
SCHEMBL12101788 0.90 MAPT (0.50) KDM4EMAPTMEN1KMT2AUSP2
SCHEMBL5014433 0.88 MAPT (0.51) F2ELANECTSGCTRCKDM4E
SCHEMBL5450752 0.86 MAPT (0.54) KDM4EMAPTMEN1KMT2AUSP2
SCHEMBL8121430 0.86 MAPT (0.54) KDM4EMAPTMEN1KMT2AUSP2
SCHEMBL8115352 0.86 MAPT (0.54) KDM4EMAPTMEN1KMT2AUSP2
SCHEMBL4578069 0.86 MAPT (0.54) KDM4EMAPTMEN1KMT2AUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070130702-A1 Dyeing process using a specific compound containing active methylene and a compound chosen from a specific aldehyde, a specific ketone, a quinone and a diiminoisoindoline or 3-aminoisoindolone derivative L'OREAL S.A. 2007-06-14 US claimed
US-4382983-A PARTIALLY HYDROLYZED SILOXANE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1983-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070130702-A1 Dyeing process using a specific compound containing active methylene and a compound chosen from a specific aldehyde, a specific ketone, a quinone and a diiminoisoindoline or 3-aminoisoindolone derivative KRT18, NDUFB5, NDUFB7 F2 1470/4885ELANE 4331/4885CTSG 4106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.